Published in J Biol Chem on January 06, 2010
DNase footprint signatures are dictated by factor dynamics and DNA sequence. Mol Cell (2014) 1.94
Role of Fos-related antigen 1 in the progression and prognosis of ductal breast carcinoma. Histopathology (2011) 0.89
SOX7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells. World J Gastroenterol (2011) 0.86
c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol Cell Biol (2010) 0.86
The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells. J Biol Chem (2013) 0.85
An NF-kappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells. PLoS One (2010) 0.84
Analysis of computational footprinting methods for DNase sequencing experiments. Nat Methods (2016) 0.82
Genome-wide footprinting: ready for prime time? Nat Methods (2016) 0.82
Imaging Fos-Jun transcription factor mobility and interaction in live cells by single plane illumination-fluorescence cross correlation spectroscopy. PLoS One (2015) 0.76
Telomerase reverse transcriptase promotes the proliferation of human laryngeal carcinoma cells through activation of the activator protein 1. Oncol Lett (2013) 0.76
Net expression inhibits the growth of pancreatic ductal adenocarcinoma cell PL45 in vitro and in vivo. PLoS One (2013) 0.76
BGRMI: A method for inferring gene regulatory networks from time-course gene expression data and its application in breast cancer research. Sci Rep (2016) 0.75
Oxidant exposure induces cysteine-rich protein 61 (CCN1) via c-Jun/AP-1 to reduce collagen expression in human dermal fibroblasts. PLoS One (2014) 0.75
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer (2003) 8.88
Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol (2002) 6.05
AP-1 subunits: quarrel and harmony among siblings. J Cell Sci (2004) 5.08
FRAP analysis of binding: proper and fitting. Trends Cell Biol (2005) 4.00
AP-1 in mouse development and tumorigenesis. Oncogene (2001) 3.93
Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene (2001) 3.83
From fixed to FRAP: measuring protein mobility and activity in living cells. Nat Cell Biol (2001) 3.76
Classification of human B-ZIP proteins based on dimerization properties. Mol Cell Biol (2002) 3.04
PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation. Cell (2000) 2.88
The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell (1989) 2.84
Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol Cell Biol (2001) 2.47
A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol (2004) 2.30
c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature (1994) 2.16
Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci U S A (1993) 2.12
Macromolecular dynamics in living cell nuclei revealed by fluorescence redistribution after photobleaching. Histochem Cell Biol (2001) 1.93
A switch in mitotic histone H4 lysine 20 methylation status is linked to M phase defects upon loss of HCF-1. Mol Cell (2004) 1.91
Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol Cell Biol (1991) 1.91
Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci (2006) 1.78
Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol Cell Biol (1992) 1.66
Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Mol Cell Biol (2003) 1.62
Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta (2006) 1.61
Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell (1990) 1.59
A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. Genes Dev (2006) 1.56
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol (2005) 1.55
The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J (1995) 1.55
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther (2008) 1.54
SUMO under stress. Biochem Soc Trans (2008) 1.47
Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity (2009) 1.43
Graded mitogen-activated protein kinase activity precedes switch-like c-Fos induction in mammalian cells. Mol Cell Biol (2005) 1.42
Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol (2005) 1.42
Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol Cell Biol (2003) 1.38
Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J Biol Chem (2005) 1.36
Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J Cell Biol (2008) 1.36
Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J Biol Chem (2002) 1.33
Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem (2006) 1.31
Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol Cell (2006) 1.27
Semirational design of Jun-Fos coiled coils with increased affinity: Universal implications for leucine zipper prediction and design. Proc Natl Acad Sci U S A (2006) 1.27
Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem (2005) 1.25
c-fos proto-oncogene regulation and function. Crit Rev Oncol Hematol (1994) 1.25
Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J Biol Chem (2005) 1.18
Trans-dominant negative mutants of Fos and Jun. Proc Natl Acad Sci U S A (1990) 1.18
Nuclear import of c-Jun is mediated by multiple transport receptors. J Biol Chem (2007) 1.17
Comparative analysis of the intracellular localization of c-Myc, c-Fos, and replicative proteins during cell cycle progression. Mol Cell Biol (1992) 1.16
Antiandrogens prevent stable DNA-binding of the androgen receptor. J Cell Sci (2005) 1.16
Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages. Proc Natl Acad Sci U S A (2005) 1.14
Dynamic interactions of a transcription factor with DNA are accelerated by a chromatin remodeller. EMBO Rep (2004) 1.12
An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry. Mol Cell Biol (2004) 1.12
The androgen receptor ligand-binding domain stabilizes DNA binding in living cells. J Struct Biol (2004) 1.11
c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol Cell Biol (2003) 1.06
The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression. Oncogene (2003) 1.04
The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1. Cell Signal (2006) 1.04
The role of nuclear organization in cancer. J Pathol (2010) 1.02
Distinct effects of topoisomerase I and RNA polymerase I inhibitors suggest a dual mechanism of nucleolar/nucleoplasmic partitioning of topoisomerase I. J Biol Chem (2004) 0.99
Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J Biol Chem (2007) 0.99
Unravelling the nuclear matrix proteome. J Proteomics (2008) 0.98
c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells. Mol Biol Cell (2004) 0.95
Transportin is a major nuclear import receptor for c-Fos: a novel mode of cargo interaction. J Biol Chem (2006) 0.94
c-Fos associates with the endoplasmic reticulum and activates phospholipid metabolism. FASEB J (2001) 0.93
Ligands differentially modify the nuclear mobility of estrogen receptors alpha and beta. Endocrinology (2007) 0.93
Identification of a nuclear targeting sequence in the Fos protein. Oncogene (1991) 0.91
Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer? Biochimie (2007) 0.91
Glutamine rich and basic region/leucine zipper (bZIP) domains stabilize cAMP-response element-binding protein (CREB) binding to chromatin. J Biol Chem (2005) 0.88
ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos. Cell Signal (2009) 0.88
The relationship between intranuclear mobility of the NF-kappaB subunit p65 and its DNA binding affinity. J Biol Chem (2006) 0.87
Revealing protein dynamics by photobleaching techniques. Methods Mol Biol (2004) 0.85
Cytoplasmic c-Fos induced by the YXXQ-derived STAT3 signal requires the co-operative MEK/ERK signal for its nuclear translocation. Genes Cells (2004) 0.83
Fos family protein degradation by the proteasome. Biochem Soc Trans (2008) 0.80
Mutations in the AF-2 region abolish ligand-induced intranuclear immobilization of the liver X receptor alpha. Exp Cell Res (2008) 0.79
CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell (2002) 2.77
Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol (2010) 2.27
The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem (2003) 2.02
Ubiquitin-independent degradation of proteins by the proteasome. Biochim Biophys Acta (2008) 1.69
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol (2005) 1.55
SUMO under stress. Biochem Soc Trans (2008) 1.47
SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1. J Cell Biol (2004) 1.24
Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Mol Cell Biol (2007) 1.16
c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol Cell Biol (2003) 1.06
N-cadherin association with lipid rafts regulates its dynamic assembly at cell-cell junctions in C2C12 myoblasts. Mol Biol Cell (2005) 1.06
N-cadherin/p120 catenin association at cell-cell contacts occurs in cholesterol-rich membrane domains and is required for RhoA activation and myogenesis. J Biol Chem (2009) 1.05
The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression. Oncogene (2003) 1.04
SUMOylation regulates the transcriptional activity of JunB in T lymphocytes. J Immunol (2008) 1.03
The pleckstrin homology domain of the Arf6-specific exchange factor EFA6 localizes to the plasma membrane by interacting with phosphatidylinositol 4,5-bisphosphate and F-actin. J Biol Chem (2008) 1.01
Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J Biol Chem (2007) 0.99
Quantitative imaging of molecular order in lipid membranes using two-photon fluorescence polarimetry. Biophys J (2009) 0.96
Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells. Virology (2005) 0.96
Interaction with 14-3-3 adaptors regulates the sorting of hMex-3B RNA-binding protein to distinct classes of RNA granules. J Biol Chem (2008) 0.94
JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis. Mol Cell Biol (2008) 0.93
A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy. PLoS Pathog (2010) 0.92
Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer? Biochimie (2007) 0.91
A novel role for PA28gamma-proteasome in nuclear speckle organization and SR protein trafficking. Mol Biol Cell (2008) 0.91
MAP1A light chain-2 interacts with GTP-RhoB to control epidermal growth factor (EGF)-dependent EGF receptor signaling. J Biol Chem (2007) 0.87
Rac1 and RhoA GTPases have antagonistic functions during N-cadherin-dependent cell-cell contact formation in C2C12 myoblasts. Biol Cell (2007) 0.86
High in vivo production of a model monoclonal antibody on adenoviral gene transfer. Hum Gene Ther (2002) 0.84
An NF-kappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells. PLoS One (2010) 0.84
Efficient gene transfer into spleen cells of newborn mice by a replication-competent retroviral vector. Virology (2002) 0.84
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation. Genet Vaccines Ther (2004) 0.82
Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment. J Virol (2005) 0.82
Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies. Blood (2012) 0.82
Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor. J Virol (2003) 0.81
Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody. J Virol (2010) 0.80
Electromediated formation of DNA complexes with cell membranes and its consequences for gene delivery. Biochim Biophys Acta (2010) 0.80
Endogenous cytotoxic T-cell response contributes to the long-term antiretroviral protection induced by a short period of antibody-based immunotherapy of neonatally infected mice. J Virol (2007) 0.80
Multiple degradation pathways for Fos family proteins. Ann N Y Acad Sci (2002) 0.80
Fos family protein degradation by the proteasome. Biochem Soc Trans (2008) 0.80
Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy. J Virol (2006) 0.79
Mechanisms of delivery of ubiquitylated proteins to the proteasome: new target for anti-cancer therapy? Crit Rev Oncol Hematol (2005) 0.79
Visualization of membrane loss during the shrinkage of giant vesicles under electropulsation. Biophys J (2009) 0.79
The effects of N-terminal insertion into VSV-G of an scFv peptide. Virol J (2006) 0.79
The insertion of an anti-MHC I ScFv into the N-terminus of an ecotropic MLV glycoprotein does not alter its fusiogenic potential on murine cells. Virus Res (2002) 0.79
Evidence for electro-induced membrane defects assessed by lateral mobility measurement of a GPi anchored protein. Eur Biophys J (2014) 0.79
Skin as a potential organ for ectopic monoclonal antibody production. J Invest Dermatol (2002) 0.78
In vivo infection of mice by replication-competent MLV-based retroviral vectors. Methods Mol Med (2003) 0.78
Monoclonal antibody-based genetic immunotherapy. Curr Gene Ther (2004) 0.77
Chromatin loop organization of the junb locus in mouse dendritic cells. Nucleic Acids Res (2013) 0.76
Centrosomal targeting of Syk kinase is controlled by its catalytic activity and depends on microtubules and the dynein motor. FASEB J (2012) 0.76
[Theory, principles and applications of fluorescent technologies in cellular biology and cancer research]. Bull Cancer (2007) 0.75
[Vaccine-like effects of antiviral monoclonal antibodies: a novel therapeutic perspective?]. Med Sci (Paris) (2013) 0.75
Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses. Biochem Pharmacol (2002) 0.75
New insights in the gene electrotransfer process: evidence for the involvement of the plasmid DNA topology. Curr Gene Ther (2012) 0.75
[Proteasomal degradation: from addressing of substrates to therapeutical perspectives]. Med Sci (Paris) (2005) 0.75